It has been already found for the critical roles of eIF4E in tumor cell growth, proliferation and migration while inhibition of eIF4E would attenuate the malignancy of tumor cells and increase the sensitivity of RCC cells to chemotherapy and immunotherapy (Woodard et al., 2008; Cao et al., 2018). The gene discussed is EIF4E; the disease is neoplasm.